At ImmuNOA, our mission is to revolutionize immunotherapy by rationally designing and testing antisense oligonucleotides that enhance the body's natural defenses against cancer and other diseases, leading to more effective and targeted treatments with fewer side effects.
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2018 (7 years)
Address:
77 AYER RAJAH CRES; SINGAPORE, 13, SG
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
LOW
spending power
